2Goran Z Stanojevic,Milica D Nestorovic,Branko R Brankovic,Miroslav P Stojanovic,Milan M Jovanovic,Milan D Radojkovic.Primary colorectal lymphoma:An overview[J].World Journal of Gastrointestinal Oncology,2011,3(1):14-18. 被引量:15
7APDW2004 Chinese IBD WORKING Group. Retrospective analysis of 515 cases of Crohn disease hospitalization in China: nationwide study from 1990 to 2003. J Gastroenterol Hepatol,2006 ,21:1009-1015.
8LawranceIC, Hall A, Leong R, et al. A comparative study of goblet celland pancreatic exocine autoantibodies combined with ASCA and pAN- CA in Chinese and Caucasian patients with IBD. Inflamm Bowel Dis, 2005,11 :g90-897.
9Sydora M J, Sydora BC, Fedorak RN. Validation of a point-of-care desk top device to quantitate fecal ealprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome. J Crohns Colitis ,2012,6: 207-214.
10Milanovic N, Matkovic S, Ristic D, et al. Significance of tumor burden, vascular endothelial growth factor,lactate dehydrogenase and beta-2 mi- croglobulin serum levels in advanced diffuse large B cell lymphoma. J BUON ,2012,17:497-501.